All News Intra-Cellular Therapies, Inc.

Equities

ITCI

US46116X1019

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-21 pm EDT			5-day change	1st Jan Change
67 ^USD	+2.57%		+1.96%	-6.45%

May. 16	Transcript : Intra-Cellular Therapies, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM
May. 07	Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Transcript : Intra-Cellular Therapies, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 09:20 AM	May. 16
Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences	May. 08	AQ
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday	May. 07	MT
Transcript : Intra-Cellular Therapies, Inc., Q1 2024 Earnings Call, May 07, 2024	May. 07
Intra-Cellular Therapies' Q1 Net Loss Narrows, Net Total Revenue Rises	May. 07	MT
Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q1 Revenue $144.9M	May. 07	MT
Earnings Flash (ITCI) INTRA-CELLULAR THERAPIES Posts Q1 Revenue $144.9M	May. 07	MT
Intra-Cellular Therapies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 07	CI
Intra-Cellular: Q1 Earnings Snapshot	May. 07	AQ
Intra-Cellular Therapies Reports First Quarter 2024 Financial Results	May. 07	AQ
Intra-Cellular Therapies, Inc. Reiterates Earnings Guidance for the Full Year 2024	May. 07	CI
Intra-Cellular Therapies to Host First Quarter 2024 Financial Results Conference Call and Webcast	Apr. 30	AQ
Intra-Cellular Therapies Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	Apr. 24	AQ
Canaccord Genuity Raises Intra-Cellular Therapies' Price Target to $107 From $100, Maintains Buy Rating	Apr. 23	MT
Needham & Co Adjusts Intra-Cellular Therapies Price Target to $90 From $82, Maintains Buy Rating	Apr. 22	MT
Mizuho Raises Price Target on Intra-Cellular Therapies to $96 From $82, Keeps Buy Rating	Apr. 22	MT
Intra-Cellular Therapies Prices Public Offering of Common Stock - April 18, 2024	Apr. 19	AQ
Intra-Cellular Therapies Prices $500 Million Stock Offering	Apr. 18	MT
Intra-Cellular Therapies Prices Public Offering of Common Stock	Apr. 17	AQ
Goldman Sachs Adjusts Price Target on Intra-Cellular Therapies to $77 From $67, Maintains Neutral Rating	Apr. 17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Intra-Cellular Therapies, Inc.

Equities

ITCI

US46116X1019

All News

Filters